Menu
Live News EQUITY M impact

TLSA Completes Dosing

Tiziana announces last patient successfully dosed in its Phase 2 INFORM-MS trial

TLSA

TLSA - Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial